Upper extremity venous thrombosis in patients with cancer with peripherally inserted central venous catheters: A retrospective analysis of risk factors

Journal of Oncology Practice

Volumn 9, Issue 1, 2013, Pages

  Ahn, Daniel H ^a   Illum, Henrik Bo ^b   Wang, David H ^b   Sharma, Anant ^b   Dowell, Jonathan E ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ANTITHROMBOCYTIC AGENT; BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ARM DISEASE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; DISEASE ASSOCIATION; FEMALE; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; RETROSPECTIVE STUDY; RISK FACTOR; VEIN THROMBOSIS;

EID: 84877753361     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2012.000595     Document Type: Article

References (25)

1. Sud R, Khorana AA: Cancer-associated thrombosis: Risk factors, candidate biomarkers and a risk model. Thromb Res 123:S18-S21, 2009-7 (suppl 4)
2. Saber W, Moua T, Williams EC, et al: Risk factors for catheter-related thrombosis (CRT) in cancer patients: A patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost 9: 312-319, 2011
3. Tian G, Zhu Y, Qi L, et al: Efficacy of multifaceted interventions in reducing complications of peripherally inserted central catheter in adult oncology patients. Support Care Cancer 18: 1293-1298, 2010
4. Ng PK, Ault MJ, Ellrodt AG, et al: Peripherally inserted central catheters in general medicine. Mayo Clin Proc 72: 225-233, 1997
5. Last KW, Mansi JK, Oakley C, et al: Long term intravenous access devices: Superiority of peripherally inserted central cannulae (PICCs) over Hickman catheters (HCs). Ann Oncol 9:142, 1998-7 (suppl 4)
6. Shivakumar SP, Anderson DR, Couban S: Catheter-associated thrombosis in patients with malignancy. J Clin Oncol 27: 4858-4864, 2009
7. Kuter DJ: Thrombotic complications of central venous catheters in cancer patients. Oncologist 9: 207-216, 2004
8. Lee AY, Levine MN, Butler G, et al: Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 24:1404- 1408, 2006
9. Eastridge BJ, Lefor AT: Complications of indwelling venous access devices in cancer patients. J Clin Oncol 13: 233-238, 1995
10. Verso M, Agnelli G: Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 21: 3665-3675, 2003
11. Walshe LJ, Malak SF, Eagan J, et al: Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol 20: 3276-3281, 2002
12. King MM, Rasnake MS, Rodriguez RG, et al: Peripherally inserted central venous catheter-associated thrombosis: Retrospective analysis of clinical risk factors in adult patients. South Med J 99: 1073-1077, 2006
13. Tran H, Arellano M, Chamsuddin MA, et al: Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leuk Lymphoma 51: 1473-1477, 2010
14. Cheong K, Perry D, Karapetis C, et al: High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours. Intern Med J 34: 234-238, 2004
15. Beckers MM, Ruven HJ, Seldenrijk CA, et al: Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer. Thromb Res 125: 318-321, 2010
16. Mermel LA: Prevention of intravascular catheter-related infections. Ann Intern Med 132: 391-402, 2000
17. Mermel LA, Farr BM, Sherertz RJ, et al: Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32: 1249-1272, 2001
18. O'Grady N, Alexander M, Dellinger EP, et al: Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 30: 476-489, 2002
19. Schmidt M, Horvath-Puho ME, Thomsen RW, et al: Acute infections and venous thromboembolism. J Intern Med 271: 608-618, 2012
20. Rothberg MB, Lindenauer PK, Lahti M, et al: Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med 6:202- 209, 2011
21. Khorana AA, Connolly GC: Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 27: 4839-4847, 2009
22. Khorana AA, Francis CW, Culakova E, et al: Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110: 2339-2346, 2007
23. Kro? ger K, Weiland D, Ose C, et al: Risk factors for venous thromboembolic events in cancer patients. Ann Oncol 17: 297-303, 2006
24. Streiff MB: Diagnosis and initial treatment of venous thromboembolism in patients with cancer. J Clin Oncol 27: 4889-4894, 2009
25. Rana P, Levine MN: Prevention of thrombosis in ambulatory patients with cancer. J Clin Oncol 27: 4885-4888, 2009